Raman spectroscopy, a potential tool in diagnosis and prognosis of castration-resistant prostate cancer

Journal of Biomedical Optics

Volumn 18, Issue 8, 2013, Pages

  Wang, Lei ^a   He, Dalin ^a   Zeng, Jin ^a   Guan, Zhenfeng ^a   Dang, Qiang ^a   Wang, Xinyang ^a   Wang, Jun ^a   Huang, Liqing ^a   Cao, Peilong ^a   Zhang, Guanjun ^a   Hsieh, Jertong ^b   Fan, Jinhai ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

androgen dependent prostate cancer; castration resistant prostate cancer; prediction; Raman spectroscopy

Indexed keywords

ANDROGEN-DEPENDENT; CELL LINES; CLINICAL PRACTICES; DIAGNOSIS AND PROGNOSIS; LEAVE-ONE-OUT CROSS VALIDATIONS; POTENTIAL TOOL; PROSTATE CANCERS; SPECTRAL CHANGE;

AMINO ACIDS; CELL CULTURE; FORECASTING; HISTOLOGY; PRINCIPAL COMPONENT ANALYSIS; RAMAN SPECTROSCOPY; SUPPORT VECTOR MACHINES; TISSUE;

DISEASES;

ALGORITHM; ARTICLE; CASTRATION RESISTANT PROSTATE CANCER; COMPUTER ASSISTED DIAGNOSIS; EVALUATION STUDY; FEASIBILITY STUDY; HUMAN; MALE; METHODOLOGY; PRINCIPAL COMPONENT ANALYSIS; PROGNOSIS; RAMAN SPECTROMETRY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; SUPPORT VECTOR MACHINE; TUMOR CELL LINE; PROCEDURES; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;

ALGORITHMS; CELL LINE, TUMOR; DATA INTERPRETATION, STATISTICAL; DIAGNOSIS, COMPUTER-ASSISTED; FEASIBILITY STUDIES; HUMANS; MALE; PRINCIPAL COMPONENT ANALYSIS; PROGNOSIS; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTRUM ANALYSIS, RAMAN; SUPPORT VECTOR MACHINES;

EID: 84890094138     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.18.8.087001     Document Type: Article

References (37)

1. B. K. Edwards et al., "Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates," Cancer 116(3), 544-573 (2010).
2. A. Heidenreich et al., "EAU guidelines on prostate cancer," Eur. Urol. 53(1), 68-80 (2008). (Pubitemid 350166735)
3. E. D. Crawford et al., "A controlled trial of leuprolide with and without flutamide in prostatic carcinoma," N. Engl. J. Med. 321(7), 419-424 (1989). (Pubitemid 19211484)
4. M. A. Eisenberger et al., "Bilateral orchiectomy with or without flutamide for metastatic prostate cancer," N. Eng. J. Med. 339(15), 1036-1042 (1998). (Pubitemid 28457865)
5. L. J. Denis et al., "Maximal androgen blockade: final analysis of EORTC phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center," Eur. Urol. 33(2), 144-151 (1998).
6. I. F. Tannock et al., "Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer," N. Engl. J. Med. 351(15), 1502-1512 (2004). (Pubitemid 39315317)
7. D. P. Petrylak et al., "Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer," N. Engl. J. Med. 351(15), 1513-1520 (2004). (Pubitemid 39315318)
8. C. Kwak et al., "Prognostic significance of the nadir prostate specific antigen level after hormone therapy for prostate cancer," J. Urol. 168(3), 995-1000 (2002).
9. S. P. Huang et al., "Impact of prostate-specific antigen (PSA) nadir and time to PSA nadir on disease progression in prostate cancer treated with androgen-deprivation therapy," Prostate 71(11), 1189-1197 (2011).
10. R. D. Malik et al., "Three-year postoperative ultrasensitive prostate-specific antigen following open radical retropubic prostatectomy is a predictor for delayed biochemical recurrence," Eur. Urol. 60(3), 548-553 (2011).
11. A. Billis et al., "The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies," J. Urol. 180(2), 548-552 (2008).
12. E. A. Benaim, C. M. Pace, and C. G. Roehrborn, "Gleason score predicts androgen independent progression after androgen deprivation therapy," Eur. Urol. 42(1), 12-17 (2002). (Pubitemid 35339640)
13. T. Uesugi et al., "Primary Gleason grade 4 impact on biochemical recurrence after permanent interstitial brachytherapy in Japanese patients with low-or intermediate-risk prostate cancer," Int. J. Radiat. Oncol. Biol. Phys. 82(2), e219-e223 (2012).
14. P. Crow et al., "The use of Raman spectroscopy to identify and characterize transitional cell carcinoma in vitro," BJU Int. 93(9), 1232-1236 (2004). (Pubitemid 38823943)
15. B. W. de Jong et al., "Discrimination between nontumor bladder tissue and tumor by Raman spectroscopy," Anal. Chem. 78(22), 7761-7769 (2006). (Pubitemid 44788720)
16. R. O. Draga et al., "In vivo bladder cancer diagnosis by high-volume Raman spectroscopy," Anal. Chem. 82(14), 5993-5999 (2010).
17. A. Shapiro et al., "Raman molecular imaging: a novel spectroscopic technique for diagnosis of bladder cancer in urine specimens," Eur. Urol. 59(1), 106-112 (2011).
18. K. Bensalah et al., "Raman spectroscopy: a novel experimental approach to evaluating renal tumours," Eur. Urol. 58(4), 602-608 (2010).
19. P. Crow et al., "The use of Raman spectroscopy to differentiate between different prostatic adenocarcinoma cell lines," Br. J. Cancer 92(12), 2166-2170 (2005). (Pubitemid 40966252)
20. G. N. Thalmann et al., "Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer," Cancer Res. 54(10), 2577-2581 (1994). (Pubitemid 24173741)
21. D. Zhang et al., "PrLZ protects prostate cancer cells from apoptosis induced by androgen deprivation via the activation of Stat3/Bcl-2 pathway," Cancer Res. 71(6), 2193-2202 (2011).
22. F. Draux et al., "Raman spectral imaging of single cancer cells: probing the impact of sample fixation methods," Anal. Bioanal. Chem. 397(7), 2727-2737 (2010).
23. F. M. Lyng et al., "Vibrational spectroscopy for cervical cancer pathology, from biochemical analysis to diagnostic tool," Exp. Mol. Pathol. 82(2), 121-129 (2007). (Pubitemid 46483386)
24. J. I. Epstein et al., "The 2005 International Society of Urologic Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma," Am. J. Surg. Pathol. 29(9), 1228-1242 (2005). (Pubitemid 41232997)
25. M. S. Bergholt et al., "In vivo diagnosis of gastric cancer using Raman endoscopy and ant colony optimization techniques," Int. J. Cancer 128(11), 2673-2680 (2011).
26. S. Haldar, A. Basu, and C. M. Croce, "Bcl-2 is the guardian of microtubule integrity," Cancer Res. 57(2), 229-233 (1997).
27. A. M. Stapleton et al., "Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases," Clin. Cancer Res. 3(8), 1389-1397 (1997). (Pubitemid 27362401)
28. M. J. Linja et al., "Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer," Cancer Res. 61(9), 3550-3555 (2001). (Pubitemid 32694958)
29. P. Crow et al., "The use of Raman spectroscopy to identify and grade prostatic adenocarcinoma in vitro," Br. J. Cancer 89(1), 106-108 (2003). (Pubitemid 36897944)
30. R. Kong, R. K. Reddy, and R. Bhargava, "Characterization of tumor progression in engineered tissue using infrared spectroscopic imaging," Analyst 135(7), 1569-1578 (2010).
31. D. C. Fernandez et al., "Infrared spectroscopic imaging for histopathologic recognition," Nat. Biotechnol. 23(4), 469-474 (2005). (Pubitemid 41724923)
32. J. T. Kwak et al., "Multimodal microscopy for automated histologic analysis of prostate cancer," BMC Cancer 11(1), 62 (2011).
33. T. J. Harvey et al., "Discrimination of prostate cancer cells by reflection mode FTIR photoacoustic spectroscopy," Analyst 132(4), 292-295 (2007). (Pubitemid 46494496)
34. E. Gazi et al., "A correlation of FTIR spectra derived from prostate cancer biopsies with gleason grade and tumour stage," Eur. Urol. 50(4), 750-760 (2006).
35. R. Bhargava, "Towards a practical Fourier transform infrared chemical imaging protocol for cancer histopathology," Anal. Bioanal. Chem. 389(4), 1155-1169 (2007). (Pubitemid 47482262)
36. E. Ó. Faoláin et al., "Raman spectroscopic evaluation of efficacy of current paraffin wax section dewaxing agents," J. Histochem. Cytochem. 53(1), 121-129 (2005). (Pubitemid 40136642)
37. F. L. Martin et al., "Distinguishing cell types or populations based on the computational analysis of their infrared spectra," Nat. Protoc. 5(11), 1748-1760 (2010).